protease inhibitor regimen Latest Research Papers

Lipodystrophy is a complication of patients on antiretroviral (ARV) medication; however, it is commonest in patients on long-term treatment and those on protease inhibitor (PI) regimens.1,2 We present a rare case of atypical lipodystrophy, presenting as multiple subcutaneous lipomas, in a patient who had been on a non-PI ART regimen for 6 weeks.

Download Full-text

Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double-Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)

The Journal of Clinical Pharmacology ◽

10.1177/0091270009339739 ◽

2010 ◽

Vol 50 (4) ◽

pp. 392-400 ◽

Cited By ~ 3

Author(s):

Martin S. Rhee ◽

James A. Hellinger ◽

Sandy Sheble-Hall ◽

Calvin J. Cohen ◽

David J. Greenblatt

Keyword(s):

Protease Inhibitor ◽

Hiv Patients ◽

Protease Inhibitor Regimen ◽

Inhibitor Regimen

Download Full-text

protease inhibitor regimen
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Will HIV-positive individuals who have drug resistance and have suppressed amount of virus in the blood on protease inhibitor regimen still remain suppressed if switched to a regimen containing bictegravir, emtricitabine and tenofovir alafenamide?

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen

Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4)

004.4 Pill dumping in adolescents receiving a boosted protease inhibitor regimen as part of second-line antiretroviral therapy: experiences from an urban HIV clinic

Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen

Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen

Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double-Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)

Export Citation Format

protease inhibitor regimenRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Will HIV-positive individuals who have drug resistance and have suppressed amount of virus in the blood on protease inhibitor regimen still remain suppressed if switched to a regimen containing bictegravir, emtricitabine and tenofovir alafenamide?

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen

Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4)

004.4 Pill dumping in adolescents receiving a boosted protease inhibitor regimen as part of second-line antiretroviral therapy: experiences from an urban HIV clinic

Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen

Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen

Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double-Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)

protease inhibitor regimen
Recently Published Documents